Bupropion HCl Neuraxpharm 300 mg tabletten met gereguleerde afgifte

This medicine has been approved for use for the indication as stated here. Availability: Uitsluitend recept

About this medicine

Active substance:	BUPROPIONHYDROCHLORIDE 300 mg/stuk SAMENSTELLING overeenkomend met BUPROPION 260.4 mg/stuk
ATC:	N06AX12 - Bupropion
Excipients:	AMMONIA (E 527) COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1) CYSTEINE (L-)HYDROCHLORIDE 1-WATER (E 920) ETHYLCELLULOSE (E 462) GLYCEROLDIBEHENAAT IJZEROXIDE ZWART (E 172) MACROGOL 1450 MAGNESIUMSTEARAAT (E 470b) NATRIUMLAURILSULFAAT POLYSORBAAT 80 (E 433) POVIDON K 90 (E 1201) PROPYLEENGLYCOL (E 1520) SCHELLAK GLAZE, GEDEELTELIJK VERESTERD SILICIUMDIOXIDE (E 551) SILICIUMDIOXIDE, GEHYDRATEERD (E 551) TRIETHYLCITRAAT (E 1505) ZWARTE INKT
Pharmaceutical form:	Tablet met gereguleerde afgifte
Route of Administration:	Oraal gebruik

externe link Information about Bupropion on Farmacotherapeutisch Kompas

Summary of the Product Characteristics (SmPC)

Patient information leaflet

Patient information

You can find an extensive description of the efficacy and possible adverse events of this medicine in the patient information leaflet and summary of the product characteristics.

Patient information

externe link Information about Bupropion on Apotheek.nl

externe link Information about Bupropion on Lareb.nl

Are you experiencing adverse events? Please report to the Adverse Events Centre Lareb. externe link I would like to report an adverse event

Do you need more information on sickness and health? Take a look at externe link Thuisarts.nl.

Patient information

You can find an extensive description of the efficacy and possible adverse events of this medicine in the patient information leaflet and summary of the product characteristics.

Patient information

externe link Information about Bupropion on Apotheek.nl

externe link Information about Bupropion on Lareb.nl

Are you experiencing adverse events? Please report to the Adverse Events Centre Lareb. externe link I would like to report an adverse event

Do you need more information on sickness and health? Take a look at externe link Thuisarts.nl.

Details marketing authorisation

Marketing authorisation number:RVG 122815
Procedure number:NL/H/4374/001
Authorisation
date:08 April 2019
Marketing authorisation holder:neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Strasse 23
40764 LANGENFELD (DUITSLAND)

Reports

Summary of the assessment report

Assessment report

Marketing authorisation number:	RVG 122815
Procedure number:	NL/H/4374/001
Authorisation date:	08 April 2019
Marketing authorisation holder:	neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Strasse 23 40764 LANGENFELD (DUITSLAND)